Ascendia Pharmaceutical Solutions Fourth Annual Technical Workshop Sets Attendance RecordOct 1, 2026, 2:34:34 PM
Beyond the DEA License: How Ascendia Pharmaceutical Solutions Supports Controlled Substance DevelopmentSep 29, 2026, 4:56:05 PM
Ascendia Pharmaceutical Solutions Supports Prescription Drug User Fee Act (PDUFA) RenewalAug 26, 2026, 12:35:15 PM
Technology Transfer in Phase II and Phase III: How Early Planning Reduces Risk and Accelerates Commercial ReadinessAug 11, 2026, 11:32:53 AM
Fast, Flexible and First Time Right Philosophy Creates Efficient Drug DevelopmentAug 10, 2026, 2:52:59 PM
The Overlooked Drivers of Drug Development: Analytical Rigor, Stability, and Scalable FormulationJun 12, 2026, 10:51:40 AM
Lipid Nanoparticles and RNA Therapeutics: Solving the Delivery Challenge at the Heart of Gene TherapyJun 9, 2026, 10:55:48 AM
Designing Aseptic Manufacturing for Ophthalmic Nanosuspensions: Why Facility Infrastructure MattersJun 1, 2026, 11:17:28 AM
Speed Is No Longer a Competitive Advantage within Drug Development - It’s a RequirementMay 29, 2026, 10:30:13 PM
